Phylogenomics of colistin-susceptible and resistant XDR Acinetobacter baumannii
Author(s) -
Mustapha M. Mustapha,
Bin Li,
Marissa P Pacey,
Roberta T. Mettus,
Christi L. McElheny,
C. W. Marshall,
Robert K. Ernst,
Vaughn S. Cooper,
Yohei Doi
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky290
Subject(s) - colistin , acinetobacter baumannii , acinetobacter , microbiology and biotechnology , pathogen , biology , enterobacteriaceae infections , medicine , bacteria , pseudomonas aeruginosa , antibiotics , enterobacteriaceae , gene , escherichia coli , genetics
Acinetobacter baumannii is a healthcare-associated pathogen with high rates of carbapenem resistance. Colistin is now routinely used for treatment of infections by this pathogen. However, colistin use has been associated with development of resistance to this agent.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom